Kronox Lab Sciences Ltd (KRONOX) is currently trading at 195.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Kronox Lab Sciences Limited manufactures High Purity Speciality Fine Chemicals for diverse industries. Established in 2009, it has expanded into key sectors such as pharmaceuticals, nutraceuticals, and solar industries. The company plays a crucial role in pharmaceuticals by providing essential reagents and excipients, impacting the production of APIs. Kronox's chemicals are also integral to scientific research, laboratory testing, and various formulations across agrochemicals and personal care products. The upcoming IPO aims to raise Rs 45 crore, signaling strategic capital deployment for further expansion and operational effectiveness.

Over the past 52 weeks, Kronox Lab Sciences Ltd has traded between a low of ₹96.00 and a high of ₹222.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Kronox Lab Sciences Ltd has a market capitalization of approximately 691.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Kronox Lab Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 691.80 Cr, Kronox Lab Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Kronox Lab Sciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Kronox Lab Sciences Ltd is 24.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The offer price stated in the DPS is ₹157.27 per equity share.

The offer price stated is ₹157.27 per equity share for public shareholders who tender validly during the offer period.

Indo Borax and Chemicals, along with Zenrock Chemicals as PAC, is making a mandatory open offer to buy up to 95,70,000 shares, equal to 25.79% of Kronox’s voting share capital.

It is a mandatory open offer to acquire up to 95,70,000 shares, representing 25.79% of Kronox Lab Sciences’ voting share capital, at ₹157.27 per share.